These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23323327)

  • 61. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
    Novak M; Schlagenhauf A; Bernhard H; Schweintzger S; Leschnik B; Muntean W
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):588-92. PubMed ID: 21799400
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human recombinant non pancreatic secreted platelet phospholipase A2 has anticoagulant activity in vitro on human plasma.
    Cirino G; Cicala C; Sorrentino L; Browning JL
    Thromb Res; 1993 May; 70(4):337-42. PubMed ID: 8332963
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
    Han F; Yao W; Yang X; Liu X; Gao X
    Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of hirudin versus heparin on hemocompatibility of blood contacting biomaterials: an in vitro study.
    Kopp R; Bernsberg R; Kashefi A; Mottaghy K; Rossaint R; Kuhlen R
    Int J Artif Organs; 2005 Dec; 28(12):1272-7. PubMed ID: 16404704
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods.
    Ivandic B; Zorn M
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):549-55. PubMed ID: 20834029
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anticoagulant effects of sulphonated polyisoprenes.
    Tamada Y; Murata M; Makino K; Yoshida Y; Yoshida T; Hayashi T
    Biomaterials; 1998; 19(7-9):745-50. PubMed ID: 9663749
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of CTB-001, a Recently Developed Generic of Bivalirudin.
    Han S; Kim YH; Choi HY; Kim MJ; Kim WJ; Park H; Bae KS; Lim HS
    Pharm Res; 2019 Aug; 36(10):146. PubMed ID: 31396727
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative effects of heparin and the sulfatoid GM1474 on coagulation parameters in plasma and blood from various species.
    Williams PD; Ye H; Cheng FC; Fugedi P; Tressler R
    Gen Pharmacol; 1998 Mar; 30(3):337-41. PubMed ID: 9510083
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative comparison of recombinant hirudin's antithrombotic and anticoagulant activities with those of heparin.
    Porta R; Pescador R; Mantovani M; Prino G
    Thromb Res; 1990 Feb; 57(4):639-43. PubMed ID: 2326777
    [No Abstract]   [Full Text] [Related]  

  • 71. Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs.
    Iyer L; Koza M; Iqbal O; Calabria R; Fareed J
    Thromb Res; 1993 Feb; 69(3):259-69. PubMed ID: 8475476
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigation of activated prothrombin complex concentrate as potential hirudin antidote in animal models.
    Diehl KH; Römisch J; Hein B; Jessel A; Ronneberger H; Pâques EP
    Haemostasis; 1995; 25(4):182-92. PubMed ID: 7557657
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro studies on a novel micelle-forming peptide with anticoagulant activity.
    Ramesh CV; Jayakumar R; Puvanakrishnan R
    Int J Pept Protein Res; 1995 Apr; 45(4):386-90. PubMed ID: 7601613
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of functional groups on the in vitro anticoagulant activity of chitosan sulfate.
    Huang R; Du Y; Yang J; Fan L
    Carbohydr Res; 2003 Mar; 338(6):483-9. PubMed ID: 12668103
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and Functional Pharmacokinetic Profile of APAC, a Novel Intravascular Antiplatelet and Anticoagulant.
    Craige S; Jouppila A; Humphries B; Lassila R
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):453-462. PubMed ID: 34132685
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A PK-PD model-based assessment of sugammadex effects on coagulation parameters.
    Bosch R; van Lierop MJ; de Kam PJ; Kruithof AC; Burggraaf J; de Greef R; Visser SA; Johnson-Levonas AO; Kleijn HJ
    Eur J Pharm Sci; 2016 Mar; 84():9-17. PubMed ID: 26747019
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Increased plasma anti-Xa activity and recovery of heparin from urine suggest absorption of orally administered unfractionated heparin in human subjects.
    Hiebert LM; Wice SM; Ping T
    J Lab Clin Med; 2005 Mar; 145(3):151-5. PubMed ID: 15871307
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Some properties of autoprothrombin II-A anticoagulant.
    Emekli NB; Ulutin ON
    Bibl Haematol; 1977; 44():15-20. PubMed ID: 617778
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacodynamics of the anticoagulant activity (APTT) of an algal polysaccharide.
    Cattaneo F; Trento F; Pescador R; Porta R; Ferro L
    Thromb Res; 2002 Mar; 105(5):455-7. PubMed ID: 12062548
    [No Abstract]   [Full Text] [Related]  

  • 80. Comparison of the blood coagulation profiles of ferrets and rats.
    Takahashi S; Hirai N; Shirai M; Ito K; Asai F
    J Vet Med Sci; 2011 Jul; 73(7):953-6. PubMed ID: 21427521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.